# A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India

> **NCT01086969** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 300 (actual)

## Conditions studied

- Meningococcal Infection
- Meningitis

## Interventions

- **BIOLOGICAL:** Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)

## Key facts

- **NCT ID:** NCT01086969
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086969, "A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01086969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*